Seeking Alpha

Zalicus (ZLCS +11.1%) takes off after announcing the FDA has approved the sale of 32mg tablets...

Zalicus (ZLCS +11.1%) takes off after announcing the FDA has approved the sale of 32mg tablets for Covidien's (COV +0.6%) Exalgo pain-relief drug. The sale of 8, 12, and 16mg tablets was approved in 2010. Zalicus receives royalties on Exalgo sakes. (PR)
Comments (2)
  • QTH
    , contributor
    Comments (7) | Send Message
     
    It is good time to buy ZLCS. I am long ZLCS
    27 Aug 2012, 02:06 PM Reply Like
  • bekownage
    , contributor
    Comment (1) | Send Message
     
    long zlcs going to be same as ARNA
    28 Aug 2012, 09:54 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector